M

MeiraGTx Holdings plc

D
MGTX
USD
0.07
(1.6317%)
Market Closed
2,982.00
Volume
-2.25
EPS
-
Div Yield
-3.070423
P/E
336,523,055.32
Market Cap
Today
1.6317%
1 Week
4.306%
1 Month
1.395%
6 Months
-30.463%
12 Months
-21.014%
Year To Date
-37.892%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
AER
4.11
(4.3649%)
USD
A
ALGT
0.23
(0.5371%)
USD
A
ALK
-0.197
(-0.4955%)
USD
D
DAL
0.19
(0.4049%)
USD
H
HA
0.69
(3.9861%)
USD
J
JBLU
-0.025
(-0.4374%)
USD
L
LUV
0.045
(0.1557%)
USD
U
UAL
-0.38
(-0.7175%)
USD
S
SAVE
-0.025
(-0.9766%)
USD
Z
ZNH
(%)
USD

Title:
MeiraGTx Holdings plc

Sector:
Healthcare
Industry:
Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Do you need help or have a question?
Contact Us